{"id":10769,"date":"2016-03-02T22:45:46","date_gmt":"2016-03-02T20:45:46","guid":{"rendered":"https:\/\/mssociety.org.il\/en\/?p=10769"},"modified":"2021-01-30T12:10:53","modified_gmt":"2021-01-30T10:10:53","slug":"2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study","status":"publish","type":"post","link":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/","title":{"rendered":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b &#8211; the CogniPlus study"},"content":{"rendered":"<p><span style=\"color: #ff6600;\"><strong>Background<\/strong><\/span>: Maintaining cognitive function in multiple sclerosis is a major concern. It is a priority to identify factors that can help preserve cognition, in addition to formal treatment. Physical activity has been suggested as a possible positive influence on cognition.<\/p>\n<p><span style=\"color: #ff6600;\"><strong>Objective<\/strong><\/span>: The aim of the CogniPlus longitudinal study is to investigate the relationship of PA and cognitive function in interferon beta-1b treated patients with relapsing-remitting MS (RRMS).<\/p>\n<p><span style=\"color: #ff6600;\"><strong>Conclusion<\/strong><\/span>: Our data confirm earlier reports from crosssectional studies which found an association between cognition and PA. Longitudinal assessment in CogniPlus will further characterize the relation of cognitive function with PA, and may help improve advice to patients about behaviours that may help preserve cognitive function.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background: Maintaining cognitive function in multiple sclerosis is a major concern. It is a priority to identify factors that can help preserve cognition, in addition to formal treatment. Physical activity [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[745,384],"tags":[],"class_list":["post-10769","post","type-post","status-publish","format-standard","hentry","category-therapeutic-information-by-pharmaceutical-companies","category-articles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society\" \/>\n<meta property=\"og:description\" content=\"Background: Maintaining cognitive function in multiple sclerosis is a major concern. It is a priority to identify factors that can help preserve cognition, in addition to formal treatment. Physical activity [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\" \/>\n<meta property=\"og:site_name\" content=\"The Israel Multiple Sclerosis Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/agudaims\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-02T20:45:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-30T10:10:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"176\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/a4f88177df9bd42d818422d7d0ad4bcb\"},\"headline\":\"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b &#8211; the CogniPlus study\",\"datePublished\":\"2016-03-02T20:45:46+00:00\",\"dateModified\":\"2021-01-30T10:10:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\"},\"wordCount\":134,\"publisher\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/#organization\"},\"articleSection\":[\"Therapeutic information by pharmaceutical companies\",\"Articles\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\",\"url\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\",\"name\":\"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society\",\"isPartOf\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/#website\"},\"datePublished\":\"2016-03-02T20:45:46+00:00\",\"dateModified\":\"2021-01-30T10:10:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u05e8\u05d0\u05e9\u05d9\",\"item\":\"https:\/\/mssociety.org.il\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About Multiple Sclerosis\",\"item\":\"https:\/\/mssociety.org.il\/en\/category\/about-multiple-sclerosis\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Therapeutic information by pharmaceutical companies\",\"item\":\"https:\/\/mssociety.org.il\/en\/category\/about-multiple-sclerosis\/therapeutic-information-by-pharmaceutical-companies\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b &#8211; the CogniPlus study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#website\",\"url\":\"https:\/\/mssociety.org.il\/en\/\",\"name\":\"The Israel Multiple Sclerosis Society\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mssociety.org.il\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#organization\",\"name\":\"\u05d4\u05d0\u05d2\u05d5\u05d3\u05d4 \u05d4\u05d9\u05e9\u05e8\u05d0\u05dc\u05d9\u05ea \u05dc\u05d8\u05e8\u05e9\u05ea \u05e0\u05e4\u05d5\u05e6\u05d4\",\"url\":\"https:\/\/mssociety.org.il\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png\",\"contentUrl\":\"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png\",\"width\":600,\"height\":176,\"caption\":\"\u05d4\u05d0\u05d2\u05d5\u05d3\u05d4 \u05d4\u05d9\u05e9\u05e8\u05d0\u05dc\u05d9\u05ea \u05dc\u05d8\u05e8\u05e9\u05ea \u05e0\u05e4\u05d5\u05e6\u05d4\"},\"image\":{\"@id\":\"https:\/\/mssociety.org.il\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/agudaims\",\"https:\/\/www.youtube.com\/channel\/UCCfPf2JEIWquD7cPkWzK9ow\/videos\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/a4f88177df9bd42d818422d7d0ad4bcb\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6a37ae243f1f421abdfa60cd5f7943a1c0dac9d5faa682525f0c3f0229cc5e2d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6a37ae243f1f421abdfa60cd5f7943a1c0dac9d5faa682525f0c3f0229cc5e2d?s=96&d=mm&r=g\",\"caption\":\"admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/","og_locale":"en_US","og_type":"article","og_title":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society","og_description":"Background: Maintaining cognitive function in multiple sclerosis is a major concern. It is a priority to identify factors that can help preserve cognition, in addition to formal treatment. Physical activity [&hellip;]","og_url":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/","og_site_name":"The Israel Multiple Sclerosis Society","article_publisher":"https:\/\/www.facebook.com\/agudaims","article_published_time":"2016-03-02T20:45:46+00:00","article_modified_time":"2021-01-30T10:10:53+00:00","og_image":[{"width":600,"height":176,"url":"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#article","isPartOf":{"@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/"},"author":{"name":"admin","@id":"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/a4f88177df9bd42d818422d7d0ad4bcb"},"headline":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b &#8211; the CogniPlus study","datePublished":"2016-03-02T20:45:46+00:00","dateModified":"2021-01-30T10:10:53+00:00","mainEntityOfPage":{"@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/"},"wordCount":134,"publisher":{"@id":"https:\/\/mssociety.org.il\/en\/#organization"},"articleSection":["Therapeutic information by pharmaceutical companies","Articles"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/","url":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/","name":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b - the CogniPlus study - The Israel Multiple Sclerosis Society","isPartOf":{"@id":"https:\/\/mssociety.org.il\/en\/#website"},"datePublished":"2016-03-02T20:45:46+00:00","dateModified":"2021-01-30T10:10:53+00:00","breadcrumb":{"@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mssociety.org.il\/en\/2015-relation-between-cognitive-function-and-physical-activity-in-multiple-sclerosis-patients-treated-with-interferon-beta-1b-the-cogniplus-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u05e8\u05d0\u05e9\u05d9","item":"https:\/\/mssociety.org.il\/en\/"},{"@type":"ListItem","position":2,"name":"About Multiple Sclerosis","item":"https:\/\/mssociety.org.il\/en\/category\/about-multiple-sclerosis\/"},{"@type":"ListItem","position":3,"name":"Therapeutic information by pharmaceutical companies","item":"https:\/\/mssociety.org.il\/en\/category\/about-multiple-sclerosis\/therapeutic-information-by-pharmaceutical-companies\/"},{"@type":"ListItem","position":4,"name":"Relation between cognitive function and physical activity in multiple sclerosis patients treated with interferon beta-1b &#8211; the CogniPlus study"}]},{"@type":"WebSite","@id":"https:\/\/mssociety.org.il\/en\/#website","url":"https:\/\/mssociety.org.il\/en\/","name":"The Israel Multiple Sclerosis Society","description":"","publisher":{"@id":"https:\/\/mssociety.org.il\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mssociety.org.il\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mssociety.org.il\/en\/#organization","name":"\u05d4\u05d0\u05d2\u05d5\u05d3\u05d4 \u05d4\u05d9\u05e9\u05e8\u05d0\u05dc\u05d9\u05ea \u05dc\u05d8\u05e8\u05e9\u05ea \u05e0\u05e4\u05d5\u05e6\u05d4","url":"https:\/\/mssociety.org.il\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mssociety.org.il\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png","contentUrl":"https:\/\/mssociety.org.il\/wp-content\/uploads\/2021\/01\/mssociety-logo-1.png","width":600,"height":176,"caption":"\u05d4\u05d0\u05d2\u05d5\u05d3\u05d4 \u05d4\u05d9\u05e9\u05e8\u05d0\u05dc\u05d9\u05ea \u05dc\u05d8\u05e8\u05e9\u05ea \u05e0\u05e4\u05d5\u05e6\u05d4"},"image":{"@id":"https:\/\/mssociety.org.il\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/agudaims","https:\/\/www.youtube.com\/channel\/UCCfPf2JEIWquD7cPkWzK9ow\/videos"]},{"@type":"Person","@id":"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/a4f88177df9bd42d818422d7d0ad4bcb","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mssociety.org.il\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6a37ae243f1f421abdfa60cd5f7943a1c0dac9d5faa682525f0c3f0229cc5e2d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6a37ae243f1f421abdfa60cd5f7943a1c0dac9d5faa682525f0c3f0229cc5e2d?s=96&d=mm&r=g","caption":"admin"}}]}},"_links":{"self":[{"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/posts\/10769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/comments?post=10769"}],"version-history":[{"count":0,"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/posts\/10769\/revisions"}],"wp:attachment":[{"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/media?parent=10769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/categories?post=10769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mssociety.org.il\/en\/wp-json\/wp\/v2\/tags?post=10769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}